Inner Cosmos Inc.
The topic of this article may not meet Wikitia's general notability guideline. |
| Private | |
| Industry | Neurotechnology |
| Founded | 2016 |
| Founders | Meron Gribetz, Eric Leuthardt, Dan Moran, Ed Boyden, Darin Dougherty |
| Products | Brain–computer interfaces |
| Website | innercosmos.ai |
Inner Cosmos Inc. is an American neurotechnology company developing minimally invasive brain–computer interfaces (BCIs) for psychiatric disorders, particularly depression. The company was founded in 2016 by Meron Gribetz, Eric Leuthardt, Dan Moran, Ed Boyden, and Darin Dougherty, and is headquartered in San Francisco, California.[1][2]
History
Inner Cosmos was founded in 2016 in San Francisco by a multidisciplinary team with expertise in neuroengineering, neurosurgery, and medical device development.[1]
In 2022, Bloomberg News reported that Inner Cosmos had implanted its first patient with a device designed to treat depression by delivering electrical stimulation to the brain via an electrode array placed within the skull.[2]
Technology
According to Bloomberg, the Inner Cosmos device is implanted under the scalp and within the skull bone, without penetrating brain tissue. The system delivers targeted stimulation to brain regions associated with mood regulation.[2]
The company's approach has been compared to transcranial magnetic stimulation (TMS), a non-invasive treatment for depression, but offers potential advantages in providing continuous therapy via an implanted system.[2]
Clinical research
Bloomberg reported that Inner Cosmos initiated a first-in-human clinical trial to assess the safety and feasibility of its implant for treating treatment-resistant depression. The study was conducted under the oversight of the U.S. Food and Drug Administration and involved a small number of patients.[2]
References
External links
This article "Inner Cosmos Inc." is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.